{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:31:57Z","timestamp":1784878317397,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.humpath.2025.105903","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:10:24Z","timestamp":1754579424000},"page":"105903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["PAX5 as a diagnostic tool in unconventional acute leukemia: Establishing immunohistochemical evidence of B-cell lineage"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5911-1017","authenticated-orcid":false,"given":"Ernest F.","family":"Hidalgo Cedeno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Germans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenggang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga K.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-245X","authenticated-orcid":false,"given":"Mina L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.humpath.2025.105903_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.humpath.2025.105903_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus classification of myeloid neoplasms and acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2025.105903_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International consensus classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch"},{"issue":"18","key":"10.1016\/j.humpath.2025.105903_bib4","first-page":"2275","article-title":"The international consensus classification of acute leukemias of ambiguous lineage","volume":"141","author":"Weinberg","year":"2023","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.humpath.2025.105903_bib6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.2020010144","article-title":"Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL","volume":"138","author":"Paietta","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humpath.2025.105903_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2020.101193","article-title":"Molecular markers in ALL: clinical implications","volume":"33","author":"Kimura","year":"2020","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"10.1016\/j.humpath.2025.105903_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2643-3230.BCD-20-0229","article-title":"Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy","volume":"2","author":"Jeha","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"10.1016\/j.humpath.2025.105903_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/IJPM.IJPM_56_17","article-title":"Applicability of 2008 world Health Organization classification system of hematolymphoid neoplasms: learning experiences","volume":"61","author":"Modkharkar","year":"2018","journal-title":"Indian J Pathol Microbiol"},{"issue":"13","key":"10.1016\/j.humpath.2025.105903_bib10","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1080\/10428194.2019.1625043","article-title":"CD19 negative and dim precursor B-lineage acute lymphoblastic leukemias: real-world challenges in a targeted-immunotherapy era","volume":"60","author":"Bommannan","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.humpath.2025.105903_bib11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/00000478-200210000-00011","article-title":"The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker","volume":"26","author":"Torlakovic","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2025.105903_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ni1454","article-title":"Pax5: the guardian of B cell identity and function","volume":"8","author":"Cobaleda","year":"2007","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.humpath.2025.105903_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2013-02-482497","article-title":"Lineage-inappropriate PAX5 expression in t(8;21) acute myeloid leukemia requires signaling-mediated abrogation of polycomb repression","volume":"122","author":"Ray","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.105903_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106301","article-title":"Acute undifferentiated leukemia: data on incidence and outcomes from a large population-based database","volume":"89","author":"Qasrawi","year":"2020","journal-title":"Leuk Res"},{"issue":"25","key":"10.1016\/j.humpath.2025.105903_bib15","first-page":"S0031","article-title":"Acute lymphoblastic leuaemia with T- and B-lineage defining markers","volume":"2","author":"Shuyu","year":"2025","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.humpath.2025.105903_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/ijlh.14226","article-title":"Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts","volume":"46","author":"Chen","year":"2024","journal-title":"Int J Lab Hematol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772500190X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772500190X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:20:21Z","timestamp":1758986421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772500190X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":15,"alternative-id":["S004681772500190X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105903","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAX5 as a diagnostic tool in unconventional acute leukemia: Establishing immunohistochemical evidence of B-cell lineage","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105903"}}